Are you or a loved one wondering what to look out for if your FL returns or facing the challenges of a relapse?
Join us for an informative and empowering webinar that brings together leading experts and a patient speaker to provide a comprehensive view of managing this complex stage of the disease.
Learn how to identify if your FL returns, the latest treatment strategies from the experts and gain personal insights from someone who has experienced it first-hand. This interactive webinar will equip you with the tools to stay informed, make confident decisions, and feel more prepared.
📅 Date: Thursday, September 26th
🕒 Time: 10:30 PDT | 13:30 EDT | 18.30 BST | 19:30 CEST
🎥 Free and open to everyone! Whether you’re a patient, caregiver, or healthcare professional, this webinar is designed to provide you with the critical knowledge and tools you need to make informed decisions about relapsed follicular lymphoma.
In this 60-minute session, you will:
➢ Gain a deeper understanding of why relapse occurs and considerations for treatment options.
➢ Learn how to identify the signs of relapse and the importance of regular monitoring.
➢ Learn about the most advanced therapies currently available.
➢ Hear a real-life experience from a patient who has faced relapse and continued to thrive.
➢ Get answers to your most pressing questions from world-renowned oncologists.
Want to read more about relapsed follicular lymphoma? Visit Your Support Hub.
Have a question you want to submit in advance? Email info@theflf.org
Your input matters
We value your suggestions, feedback, and topic requests for future webinars. If there’s a specific aspect of follicular lymphoma you’d like us to cover, or any other input you’d like to share, please reach out to us. We are committed to continuously improving our webinars based on your needs and interests.
If you’re unsure about any of the terms and treatments discussed, please visit our glossary.
Dr Mitchell Smith – Chief Medical Officer, Follicular Lymphoma Foundation
Dr Mitchell Smith has an extensive educational background, having earned his Medical Degree and PhD from Case Western Reserve University School of Medicine in Cleveland, OH. He has also completed several residencies and fellowships, including a Fellowship in Medical Oncology at Memorial Sloan-Kettering Cancer Centre in NY. Dr Smith’s career has also spanned many years and institutions, including serving as Director of the Lymphoma Program at Fox Chase Cancer Centre and Director of the Lymphoid Malignancy Program at the Cleveland Clinic.
Dr Philippe Armand, Chief, Division of Lymphoma, Dana-Farber Cancer Institute
Philippe Armand obtained his MD and PhD from the University of California San Francisco. He completed a residency in Internal Medicine at Brigham and Women’s Hospital in 2004, and a fellowship in Hematology/Oncology at Dana-Farber Cancer Institute (DFCI) in 2007. Since then, he has worked in the Department of Medical Oncology at DFCI. He is currently a Professor of Medicine at Harvard Medical School, the Harold and Virginia Lash/David Lash Chair in Lymphoma Research, and the Chief of the Division of Lymphoma. His clinical practice is focused on patients with lymphoma. His research interests center on the development of novel therapeutics and assays in lymphoma, with a key focus on the translation of local laboratory research to novel clinical trials.
Andrew McAslan- Diagnosed with FL in 2021
In 2021, Andrew was diagnosed with Stage 4 Follicular Lymphoma at only 25 years old. At the time, he was involved in competitive sport training as an 800m track athlete, so the news came as a huge shock and turned his life upside down. He immediately started a course of Bendamustine and Rituximab treatment, which resulted in a complete response and no evidence of disease. Unfortunately, this remission was short-lived, and he relapsed at the end of 2022. Since then, Andrew has been on ‘Watch and Wait,’ with the progression of the disease being closely monitored. It is expected that he will need his next line of treatment in the next 6 months to 1 year.
Andrew’s experience with follicular lymphoma was initially very treatment and recovery focused, but the majority of his journey has been about life after treatment or living with relapsed follicular lymphoma. For Andrew and his family, this has been an incredibly turbulent period, dealing with the uncertainty of when his condition will decline and when treatment will be required. As someone with a young family, early in his career, and with ambitions of returning to elite sport, this stage of the disease has presented a number of challenges.
